Skip to main content

Advertisement

SpringerLink
Log in

Association between cytotoxic T lymphocyte antigen-4 +49A/G, −1722T/C, and −1661A/G polymorphisms and cancer risk: a meta-analysis

  • Research Article
  • Published:
Tumor Biology

Abstract

Cytotoxic T lymphocyte antigen-4 (CTLA-4), a key gene that contributes to the susceptibility and clinical course of cancer, is an important down-regulator of T cell activation and proliferation. The +49A/G polymorphism is commonly studied because of its association with cancer risks. However, other polymorphisms, such as −1722T/C and −1661A/G, have not been studied in detail. We performed a meta-analysis using 43 eligible case–control studies with a total of 19,089 patients and 21,388 controls to examine the association between CTLA-4 +49A/G, −1722T/C, and −1661A/G polymorphisms and cancer risk. We searched the PubMed and EMBASE databases for all articles published up to July 17, 2013. Individuals with the +49 A allele (AA/AG vs. GG, odds ratio (OR) = 1.21, 95 % confidence interval (95 % CI) = 1.16–1.27) and −1661 G allele (AG/GG vs. AA, OR = 1.52, 95 % CI = 1.34–1.73) had increased cancer risk. However, no significant association between cancer risk and the −1722T/C polymorphism was found (CC/CT vs. TT, OR = 1.04, 95 % CI = 0.92–1.16). In subgroup analysis for the +49A/G polymorphism, increased cancer risk remained in the subgroups of Asians (OR = 1.25, 95 % CI = 1.18–1.31), patients with breast cancer (OR = 1.28, 95 % CI = 1.15–1.42), and patients with lung cancer (OR = 1.20, 95 % CI = 1.07–1.35). For the −1661A/G polymorphism, increased cancer risk remained in the subgroups of Asians (OR = 1.52, 95 % CI = 1.34–1.73), patients with breast cancer (OR = 1.48, 95 % CI = 1.07–2.03), and patients with oral cancer (OR = 3.16, 95 % CI = 1.84–5.45). However, no significant increase in cancer risk was found in the subgroups for the −1722T/C polymorphism. In conclusion, the results suggest that +49A/G and −1661A/G polymorphisms in CTLA-4 are risk factors for cancers, whereas the −1722T/C polymorphism is not associated with an increased risk of cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

    Article  PubMed  Google Scholar 

  2. Andrew AS, Nelson HH, Kelsey KT, Moore JH, Meng AC, Casella DP, et al. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis. 2006;27:1030–7.

    Article  PubMed  CAS  Google Scholar 

  3. Ziogas D, Roukos DH. Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice. Ann Surg Oncol. 2009;16:1771–82.

    Article  PubMed  Google Scholar 

  4. Ghaderi A. Ctla4 gene variants in autoimmunity and cancer: a comparative review. Iran J Immunol. 2011;8:127–49.

    PubMed  CAS  Google Scholar 

  5. Srivastava PK, Duan F. Harnessing the antigenic fingerprint of each individual cancer for immunotherapy of human cancer: genomics shows a new way and its challenges. Cancer Immunol Immunother. 2013;62:967–74.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  6. Sun T, Zhou Y, Yang M, Hu Z, Tan W, Han X, et al. Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Res. 2008;68:7025–34.

    Article  PubMed  CAS  Google Scholar 

  7. Leach DR, Krummel MF, Allison JP. Enhancement of antitumor immunity by CTLA-4 blockade. Science. 1996;271:1734–6.

    Article  PubMed  CAS  Google Scholar 

  8. Ghaderi A, Yeganeh F, Kalantari T, Talei AR, Pezeshki AM, Doroudchi M, et al. Cytotoxic T lymphocyte antigen-4 gene in breast cancer. Breast Cancer Res Treat. 2004;86:1–7.

    Article  PubMed  CAS  Google Scholar 

  9. Qi P, Ruan CP, Wang H, Zhou FG, Xu XY, Gu X, et al. Ctla-4 +49a>g polymorphism is associated with the risk but not with the progression of colorectal cancer in Chinese. Int J Colorectal Dis. 2010;25:39–45.

    Article  PubMed  Google Scholar 

  10. Zhang Y, Zhang J, Deng Y, Tian C, Li X, Huang J, et al. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis. Cancer. 2011;117:4312–24.

    Article  PubMed  CAS  Google Scholar 

  11. Wang L, Li D, Fu Z, Li H, Jiang W, Li D. Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population. Bmc Cancer. 2007;7:173.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  12. Li D, Zhang Q, Xu F, Fu Z, Yuan W, Li D, et al. Association of CTLA-4 gene polymorphisms with sporadic breast cancer risk and clinical features in Han women of northeast china. Mol Cell Biochem. 2012;364:283–90.

    Article  PubMed  CAS  Google Scholar 

  13. Su TH, Chang TY, Lee YJ, Chen CK, Liu HF, Chu CC, et al. CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women. Carcinogenesis. 2007;28:1237–40.

    Article  PubMed  CAS  Google Scholar 

  14. Castro FA, Haimila K, Sareneva I, Schmitt M, Lorenzo J, Kunkel N, et al. Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population—a candidate gene approach. Int J Cancer. 2009;125:1851–8.

    Article  PubMed  CAS  Google Scholar 

  15. Pawlak E, Karabon L, Wlodarska-Polinska I, Jedynak A, Jonkisz A, Tomkiewicz A, et al. Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population. Hum Immunol. 2010;71:195–200.

    Article  PubMed  CAS  Google Scholar 

  16. Ivansson EL, Juko-Pecirep I, Gyllensten UB. Interaction of immunological genes on chromosome 2q33 and IFNG in susceptibility to cervical cancer. Gynecol Oncol. 2010;116:544–8.

    Article  PubMed  CAS  Google Scholar 

  17. Rahimifar S, Erfani N, Sarraf Z, Ghaderi A. CTLA-4 gene variations may influence cervical cancer susceptibility. Gynecol Oncol. 2010;119:136–9.

    Article  PubMed  CAS  Google Scholar 

  18. Li H, Zhou YF, Guo HY, Sun T, Zhang WH, Lin DX. Association between CTLA-4 gene polymorphism and susceptibility to cervical cancer. Zhonghua Zhong Liu Za Zhi. 2011;33:681–4.

    PubMed  CAS  Google Scholar 

  19. Jiang L, Luo RY, Zhang W, Wang LR, Wang F, Cheng YX. Single nucleotide polymorphisms of CTLA4 gene and their association with human cervical cancer. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011;28:313–7.

    PubMed  CAS  Google Scholar 

  20. Gokhale P, Kerkar S, Tongaonkar H, Salvi V, Mania-Pramanik J. CTLA-4 gene polymorphism at position +49 A>G in exon 1: a risk factor for cervical cancer in Indian women. Cancer Genet. 2013;206:154–61.

    Article  PubMed  CAS  Google Scholar 

  21. Khaghanzadeh N, Erfani N, Ghayumi MA, Ghaderi A. CTLA4 gene variations and haplotypes in patients with lung cancer. Cancer Genet Cytogenet. 2010;196:171–4.

    Article  PubMed  CAS  Google Scholar 

  22. Song B, Liu Y, Liu J, Song X, Wang Z, Wang M, et al. CTLA-4 +49A>G polymorphism is associated with advanced non-small cell lung cancer prognosis. Respiration. 2011;82:439–44.

    Article  PubMed  CAS  Google Scholar 

  23. Karabon L, Pawlak E, Tomkiewicz A, Jedynak A, Passowicz-Muszynska E, Zajda K, et al. CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer. Hum Immunol. 2011;72:947–54.

    Article  PubMed  CAS  Google Scholar 

  24. Hou R, Cao B, Chen Z, Li Y, Ning T, Li C, et al. Association of cytotoxic T lymphocyte-associated antigen-4 gene haplotype with the susceptibility to gastric cancer. Mol Biol Rep. 2010;37:515–20.

    Article  PubMed  CAS  Google Scholar 

  25. Liu Y, He Z, Feng D, Shi G, Gao R, Wu X, et al. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma. Dna Cell Biol. 2011;30:1051–5.

    Article  PubMed  CAS  Google Scholar 

  26. Cheng XL, Ning T, Xu CQ, Li Y, Zhu BS, Hou FT, et al. Haplotype analysis of CTLA4 gene and risk of esophageal squamous cell carcinoma in Anyang area of China. Hepatogastroenterology. 2011;58:432–7.

    PubMed  CAS  Google Scholar 

  27. Erfani N, Razmkhah M, Talei AR, Pezeshki AM, Doroudchi M, Monabati A, et al. Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer. Cancer Genet Cytogenet. 2006;165:114–20.

    Article  PubMed  CAS  Google Scholar 

  28. Li H, Fu ZK, Wang LH, Li DL, Wu N, Zhang J, et al. Association of cytotoxic T lymphocyte antigen-4 gene polymorphisms with susceptibility to breast cancer. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008;24:282–4.

    PubMed  CAS  Google Scholar 

  29. Monne M, Piras G, Palmas A, Arru L, Murineddu M, Latte G, et al. Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to non-Hodgkin’s lymphoma. Am J Hematol. 2004;76:14–8.

    Article  PubMed  CAS  Google Scholar 

  30. Piras G, Monne M, Uras A, Palmas A, Murineddu M, Arru L, et al. Genetic analysis of the 2q33 region containing CD28-CTLA4-ICOS genes: association with non-Hodgkin’s lymphoma. Br J Haematol. 2005;129:784–90.

    Article  PubMed  CAS  Google Scholar 

  31. Cheng TY, Lin JT, Chen LT, Shun CT, Wang HP, Lin MT, et al. Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. J Clin Oncol. 2006;24:3483–9.

    Article  PubMed  CAS  Google Scholar 

  32. Solerio E, Tappero G, Iannace L, Matullo G, Ayoubi M, Parziale A, et al. CTLA4 gene polymorphism in Italian patients with colorectal adenoma and cancer. Dig Liver Dis. 2005;37:170–5.

    Article  PubMed  CAS  Google Scholar 

  33. Hadinia A, Hossieni SV, Erfani N, Saberi-Firozi M, Fattahi MJ, Ghaderi A. CTLA-4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancers. J Gastroenterol Hepatol. 2007;22:2283–7.

    Article  PubMed  CAS  Google Scholar 

  34. Cozar JM, Romero JM, Aptsiauri N, Vazquez F, Vilchez JR, Tallada M, et al. High incidence of CTLA-4 aa (ct60) polymorphism in renal cell cancer. Hum Immunol. 2007;68:698–704.

    Article  PubMed  CAS  Google Scholar 

  35. Dilmec F, Ozgonul A, Uzunkoy A, Akkafa F. Investigation of CTLA-4 and CD28 gene polymorphisms in a group of Turkish patients with colorectal cancer. Int J Immunogenet. 2008;35:317–21.

    Article  PubMed  CAS  Google Scholar 

  36. Wong YK, Chang KW, Cheng CY, Liu CJ. Association of CTLA-4 gene polymorphism with oral squamous cell carcinoma. J Oral Pathol Med. 2006;35:51–4.

    Article  PubMed  CAS  Google Scholar 

  37. Kammerer PW, Toyoshima T, Schoder F, Kammerer P, Kuhr K, Brieger J, et al. Association of T-cell regulatory gene polymorphisms with oral squamous cell carcinoma. Oral Oncol. 2010;46:543–8.

    Article  PubMed  CAS  Google Scholar 

  38. Bharti V, Mohanti BK, Das SN. Functional genetic variants of CTLA-4 and risk of tobacco-related oral carcinoma in high-risk north Indian population. Hum Immunol. 2013;74:348–52.

    Article  PubMed  CAS  Google Scholar 

  39. Mahajan R, El-Omar EM, Lissowska J, Grillo P, Rabkin CS, Baccarelli A, et al. Genetic variants in T helper cell type 1, 2 and 3 pathways and gastric cancer risk in a Polish population. Jpn J Clin Oncol. 2008;38:626–33.

    Article  PubMed Central  PubMed  Google Scholar 

  40. Hu L, Liu J, Chen X, Zhang Y, Liu L, Zhu J, et al. CTLA-4 gene polymorphism +49 A/G contributes to genetic susceptibility to two infection-related cancers-hepatocellular carcinoma and cervical cancer. Hum Immunol. 2010;71:888–91.

    Article  PubMed  CAS  Google Scholar 

  41. Gu X, Qi P, Zhou F, Ji Q, Wang H, Dou T, et al. Gao C: +49G>A polymorphism in the cytotoxic t-lymphocyte antigen-4 gene increases susceptibility to hepatitis b-related hepatocellular carcinoma in a male Chinese population. Hum Immunol. 2010;71:83–7.

    Article  PubMed  CAS  Google Scholar 

  42. Perez-Garcia A, De la Camara R, Roman-Gomez J, Jimenez-Velasco A, Encuentra M, Nieto JB, et al. CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors. Blood. 2007;110:461–7.

    Article  PubMed  CAS  Google Scholar 

  43. Teft WA, Kirchhof MG, Madrenas J. A molecular perspective of CTLA-4 function. Annu Rev Immunol. 2006;24:65–97.

    Article  PubMed  CAS  Google Scholar 

  44. Nirschl CJ, Drake CG: Molecular pathways: co-expression of immune checkpoint molecules: signaling pathways and implications for cancer immunotherapy. Clin Cancer Res. 2013;19:4917–24.

    Google Scholar 

  45. Zhou G, Levitsky H. Towards curative cancer immunotherapy: overcoming posttherapy tumor escape. Clin Dev Immunol. 2012;2012:124187.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  46. Sun T, Hu Z, Shen H, Lin D. Genetic polymorphisms in cytotoxic T-lymphocyte antigen 4 and cancer: the dialectical nature of subtle human immune dysregulation. Cancer Res. 2009;69:6011–4.

    Article  PubMed  CAS  Google Scholar 

  47. Mao HT, Wang XB, Zhang L, Gu HT. Studies on the genetic pathogenesis of myasthenia gravis caused by CTLA-4 gene polymorphism. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004;21:574–8.

    PubMed  CAS  Google Scholar 

  48. Jones KA, Kadonaga JT, Rosenfeld PJ, Kelly TJ, Tjian R. A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication. Cell. 1987;48:79–89.

    Article  PubMed  CAS  Google Scholar 

  49. Bouqbis L, Izaabel H, Akhayat O, Perez-Lezaun A, Calafell F, Bertranpetit J, et al. Association of the CTLA4 promoter region (−1661g allele) with type 1 diabetes in the south Moroccan population. Genes Immunol. 2003;4:132–7.

    Article  CAS  Google Scholar 

  50. Zahnow CA. CCAAT/enhancer binding proteins in normal mammary development and breast cancer. Breast Cancer Res. 2002;4:113–21.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  51. Anjos SM, Shao W, Marchand L, Polychronakos C. Allelic effects on gene regulation at the autoimmunity-predisposing CTLA4 locus: a re-evaluation of the 3′ +6230G>A polymorphism. Genes Immunol. 2005;6:305–11.

    Article  CAS  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Orthopedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China

    Rui Geng, Fanglong Song, Peng Sun, Junzheng Hu, Chunhui Zhu, Binjie Zhu & Weimin Fan

  2. Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China

    Xiao Yang

Authors
  1. Rui Geng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fanglong Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiao Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peng Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Junzheng Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chunhui Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Binjie Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Weimin Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Weimin Fan.

Additional information

R. Geng, F. Song, and X. Yang contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Geng, R., Song, F., Yang, X. et al. Association between cytotoxic T lymphocyte antigen-4 +49A/G, −1722T/C, and −1661A/G polymorphisms and cancer risk: a meta-analysis. Tumor Biol. 35, 3627–3639 (2014). https://doi.org/10.1007/s13277-013-1480-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-1480-x

Keywords

Search

Navigation